Skip to main content
. Author manuscript; available in PMC: 2013 May 22.
Published in final edited form as: Acta Pharm Sin B. 2012 Aug;2(4):341–349. doi: 10.1016/j.apsb.2012.06.010

Figure 3.

Figure 3

Mitochondrial inhibition as a new approach for insulin sensitization. In obesity, mitochondria over-activation by substrates and insulin leads to reduction in AMPK activity. Insulin signaling activity is inhibited in the presence of AMPK inactivation. Inhibition of mitochondrial function is an alternative pathway in AMPK activation.